AbbVie and Gedeon Richter Plc. ('Richter') today announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions.
In recent years, ketamine has emerged as a groundbreaking treatment option for various mental health conditions, particularly depression, anxiety, PTSD, and chronic pain disorders.
Elite Psychology Group is setting a new standard in anxiety therapy, offering innovative and comprehensive solutions to individuals struggling with anxiety-related disorders.
She is board certified in general and child/adolescent psychiatry and specializes in the treatment of conditions ... the triggers that produce the anxiety. While generalized anxiety disorder ...